Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
IPI Legacy Liquidation CoListing unverified | Sell | $25.5K | SEC | |
IPI Legacy Liquidation CoListing unverified | Sell | $23K | SEC | |
IPI Legacy Liquidation CoListing unverified | Sell | $16.7K | SEC | |
IPI Legacy Liquidation CoListing unverified | Sell | $3.5K | SEC | |
IPI Legacy Liquidation CoListing unverified | Sell | $2.3K | SEC | |
IPI Legacy Liquidation CoListing unverified | Sell | $3.2K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $25.3K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $998.4 | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $3.5K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $6.2K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $7.2K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $6.5K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $1.1K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $7.6K | SEC | |
Bolt Biotherapeutics, Inc.Listing on record | Sell | $21.6K | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | Buy | $3.3M | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | Buy | $3.6K | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | BuyD (derivative) | $3.6M | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | Buy | $3.6M | SEC | |
IPI Legacy Liquidation CoListing unverified | Other | — | SEC | |
IPI Legacy Liquidation CoListing unverified | Other | $1.2M | SEC | |
IPI Legacy Liquidation CoListing unverified | OtherD (derivative) | — | SEC | |
IPI Legacy Liquidation CoListing unverified | Buy | $7.6M | SEC | |
IPI Legacy Liquidation CoListing unverified | Buy | $1M | SEC | |
IPI Legacy Liquidation CoListing unverified | Other | — | SEC |